Dirk Kersten
Director at Dyne Therapeutics, Inc. (DYN)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $38.6M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 29SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 256,0723,592,184 held (−7%) | $25.50 | $6.5M | -34.7% |
| Jul 29SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 5,3883,586,796 held (−0%) | $26.04 | $140K | -36.1% |
| Jun 24SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 190,6763,921,542 held (−5%) | $20.57 | $3.9M | -19.1% |
| Jun 24SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 71,6293,849,913 held (−2%) | $21.04 | $1.5M | -20.9% |
| Jun 24SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 1,6573,848,256 held (−0%) | $21.47 | $36K | -22.5% |
| Jun 22SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 37,4544,159,119 held (−1%) | $20.14 | $754K | -17.4% |
| Jun 22SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 46,9014,112,218 held (−1%) | $20.07 | $941K | -17.1% |
| Apr 23SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 8,3004,199,225 held (−0%) | $20.01 | $166K | -16.8% |
| Apr 23SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 2,6524,196,573 held (−0%) | $20.00 | $53K | -16.8% |
| Apr 21SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 211,9744,332,799 held (−5%) | $20.29 | $4.3M | -18.0% |
| Apr 21SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 125,2744,207,525 held (−3%) | $20.07 | $2.5M | -17.1% |
| Apr 17SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 81,8404,562,546 held (−2%) | $20.27 | $1.7M | -17.9% |
| Apr 17SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 11,1164,551,430 held (−0%) | $21.10 | $235K | -21.1% |
| Apr 17SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 6,6574,544,773 held (−0%) | $20.06 | $134K | -17.0% |
| Mar 13SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 129,6724,644,386 held (−3%) | $19.52 | $2.5M | -14.8% |
| Mar 11SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 177,6905,285,156 held (−3%) | $17.72 | $3.1M | -6.1% |
| Mar 11SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 9,4825,275,674 held (−0%) | $18.21 | $173K | -8.6% |
| Mar 11SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 219,7585,055,916 held (−4%) | $19.33 | $4.2M | -13.9% |
| Mar 11SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 281,8584,774,058 held (−6%) | $19.80 | $5.6M | -16.0% |
- Sell
Director Dirk Kersten sold $6.5M of DYN at $25.50 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Dirk Kersten sold $140K of DYN at $26.04 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Dirk Kersten sold $3.9M of DYN at $20.57 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Dirk Kersten sold $1.5M of DYN at $21.04 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Dirk Kersten sold $36K of DYN at $21.47 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Dirk Kersten sold $754K of DYN at $20.14 — pre-scheduled 10b5-1 plan sale.